New Research Shows Women May Shed More Pounds with Ozempic and Other Semaglutides

Weight loss medications such as Ozempic and similar semaglutide drugs have become widely recognized for their potential to support people trying to lose weight. However, recent research reveals that individual experiences with these medications might vary more than previously thought. This new study challenges earlier clinical trials that reported people losing up to nearly 15 percent of their body weight using these medicines.

According to the recent analysis, the average weight loss for individuals taking semaglutides like Ozempic is closer to 5 percent. This suggests that expectations for drastic weight loss should be tempered, as results differ based on several factors unique to each person. It’s important to understand how these medications function and what influences their effectiveness before starting a treatment plan.

The study was conducted by physicians and researchers from respected medical centers, including a team from the Department of Internal Medicine and Geriatrics at Cleveland Clinic. It examined medical records from nearly 3,500 patients diagnosed with obesity who were prescribed either semaglutide-based drugs like Wegovy or Ozempic or another weight loss option called liraglutide.

Their goal was to gain real-world insight into how much weight patients lost after a year of treatment outside of controlled clinical trials, providing a more practical perspective on these medications’ performance.

By analyzing such a large and diverse group of patients, the researchers were able to observe patterns in weight loss and identify factors that might affect how well these drugs work.

The study found that, on average, all patients lost about 3.7 percent of their body weight after one year of treatment. When diving deeper, those taking semaglutide drugs lost approximately 5.1 percent, while patients on liraglutide experienced around a 2.2 percent loss.

An important observation was that patients using these medications specifically for obesity tended to experience more significant weight reduction compared to those using them primarily for managing type 2 diabetes. This difference may be due in part to higher starting doses typically used for obesity treatment.

In fact, patients on semaglutide for obesity lost nearly 13 percent of their body weight within a year—results that align well with earlier clinical trials. In contrast, those on the drug for diabetes management had a more modest average loss of about 6 percent.

A particularly notable takeaway was the gender difference: women in the study were more likely to experience greater weight loss than men.

You might wonder why women seem to lose more weight while taking semaglutides like Ozempic. While the exact reasons aren’t fully understood, experts suggest hormones could play a significant role. Hormonal differences between men and women affect metabolism and fat storage, which might influence how these medications work in each body.

Additionally, women tend to have smaller body sizes on average compared to men. This means that the same dose of medication might have a more pronounced effect on someone with less overall body mass, boosting weight loss results.

It’s also worth mentioning that responses can vary widely from person to person. While women generally see better outcomes in the research, there are plenty of cases where men lose substantial weight or women experience more modest results. The effectiveness is influenced by multiple factors including lifestyle, genetics, and adherence to treatment.

The takeaway is that while gender appears to influence weight loss success on these drugs, it is only one part of a complex puzzle involving many personal variables.

Before deciding to start a weight loss medication like Ozempic, there are several crucial points to keep in mind. For one, these drugs usually require long-term use for sustained results. It’s important to consider whether you can maintain access to the medication, especially if insurance coverage is limited or costs are high. Stopping the drug prematurely may lead to regaining weight.

If you have existing digestive system issues, such as gastrointestinal disorders, semaglutide medications could potentially worsen symptoms since gastrointestinal side effects are a common concern. Discussing your full medical history with your doctor is essential to ensure safety.

Also, these medications are typically prescribed to individuals classified as having obesity based on specific criteria. They are not generally prescribed for people without such classifications, so consulting a healthcare professional will help determine if you qualify.

Beyond medication, lifestyle changes remain a cornerstone of effective weight management. Regardless of the approach—whether through counseling, medication, or surgery—sustainable habits around diet and physical activity are key. Using these drugs as a helpful tool while working on nutrition and exercise habits is the best way to achieve and maintain your goals.

Remember, successful weight loss journeys often involve a combination of medical and personal commitment. Empower yourself with knowledge, support, and realistic expectations to maximize your chances of lasting success.